0001209191-16-106294.txt : 20160304
0001209191-16-106294.hdr.sgml : 20160304
20160304210024
ACCESSION NUMBER: 0001209191-16-106294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160302
FILED AS OF DATE: 20160304
DATE AS OF CHANGE: 20160304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001411158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251854385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: 650-543-7500
MAIL ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
FORMER COMPANY:
FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: IPPOLITO VINCENT P
CENTRAL INDEX KEY: 0001430426
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34973
FILM NUMBER: 161486766
MAIL ADDRESS:
STREET 1: 8125 NORTH HAYDEN ROAD
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258-2463
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-02
0
0001411158
Anacor Pharmaceuticals, Inc.
ANAC
0001430426
IPPOLITO VINCENT P
C/O ANACOR PHARMACEUTICALS, INC.
1020 EAST MEADOW CIRCLE
PALO ALTO
CA
94303
0
1
0
0
EVP & Chief Commercial Officer
Common Stock
2016-03-02
4
S
0
1600
62.229
D
75385
D
Common Stock
2016-03-02
4
S
0
1875
63.5553
D
73510
D
Common Stock
2016-03-02
4
S
0
3696
64.2176
D
69814
D
Common Stock
2016-03-02
4
S
0
1829
64.8834
D
67985
D
This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person to cover taxes associated with the vesting of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.71 to $62.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.74 to $63.71, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.765 to $64.73, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.76 to $65.17, inclusive.
/s/ John C. Duncanson, as attorney-in-fact
2016-03-04